Home › Therapeutic areas › Oncology › Bladder Cancer
Bladder Cancer (10 companies)
Companies with an active program in Bladder Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AKTS | Aktis Oncology | Oncology | 1 | Phase 1 | 10 |
| ARTV | Artiva Biotherapeutics | DermatologyImmunology+2 Rare | 1 | Phase 2 | 14 |
| CGON | CG Oncology | Oncology | 1 | NDA Submitted | 1 |
| EXEL | Exelixis | CardiovascularOncology | 1 | Approved | 22 |
| IBRX | ImmunityBio | Infectious DiseaseOncology | 2 | Approved | 16 |
| NKTR | Nektar Therapeutics | DermatologyImmunology+2 | 1 | Phase 3 | 11 |
| TARA | Protara Therapeutics | DermatologyMetabolic+1 Rare | 1 | Phase 2 | 3 |
| RLMD | Relmada Therapeutics | MetabolicNeurology+1 Rare | 1 | Phase 2 | 4 |
| SMMT | Summit Therapeutics | Oncology | 1 | NDA Submitted | 4 |
| TYRA | Tyra Biosciences | MetabolicOncology Rare | 2 | Phase 2 | 5 |
No companies match.